LOMA LINDA, CA, Sept. 03, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing biotechnologies focused on improving the health of the immune system through immune monitoring and reprogramming, today announced that it has signed a Collaboration Agreement with… Read More..

Thursday, September 10, 2020, from 4:00-5:00 pm Eastern Time PRINCETON, N.J., Sept. 3, 2020 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it will… Read More..

Earnings Call Scheduled for 8:00 am ET on September 10, 2020 SAN JOSE, Calif., Aug. 28, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States announced today that it has rescheduled… Read More..